NAVICENT HEALTH BALDWIN — History
CCN 110150 | 3-year financial timeline | COVID resilience: 32/100
🛡️ Public data only — no PHI permitted on this instance.
$53M
Latest Revenue (FY2022)
-0.3%
Revenue CAGR (3yr)
-23.8%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $53M | $29M | $53M | +81.5% | -0.3% |
| Operating Expenses | $57M | $32M | $66M | +103.2% | +7.0% |
| Operating Margin | -7.4% | -10.6% | -23.8% | -123.9% | +0.0% |
| Net Income | $-4M | $-3M | $-13M | -306.5% | +0.0% |
| Licensed Beds | 86 | 86 | 86 | +0.0% | +0.0% |
| Total Patient Days | 14,631 | 7,739 | 12,587 | +62.6% | -7.2% |
| Medicare Day % | 23% | 24% | 21% | -13.8% | -5.9% |
| Medicaid Day % | 7% | 7% | 7% | -6.3% | -4.3% |
COVID Impact & Recovery
Resilience Score: 32/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -0.6% ($53M → $53M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▶ Stable
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-0.3%
This Hospital
+7.6%
State Avg
Latest Margin
-23.8%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $53M | -32.0% |
| FY2024 (proj) | $53M | -40.2% |
| FY2025 (proj) | $53M | -48.4% |